Video

Dr Sachin Jain: Discussion on Population Health Reveals Causes for Optimism

Among the sessions of the ACO & Emerging Healthcare Delivery Coalition Spring 2017 meeting was a panel discussion on population health strategies. According to Sachin H. Jain, MD, MBA, president and CEO of CareMore, the discussion was optimistic about the future of the healthcare system, particularly due to the new therapies and technologies that are being developed.

Among the sessions of the ACO & Emerging Healthcare Delivery Coalition Spring 2017 meeting was a panel discussion on population health strategies. According to Sachin H. Jain, MD, MBA, president and CEO of CareMore, the discussion was optimistic about the future of the healthcare system, particularly due to the new therapies and technologies that are being developed.

Transcript (slightly modified)

What is one key takeaway from the panel discussion on population health strategies at the ACO & Emerging Healthcare Delivery Coalition?

I would say the one key takeaway is that the future of healthcare is an uncertainty right now, and I think that there’s going to be lots of progress along lots of different dimensions. I think we’re going to have new therapies, new drugs that are going to solve problems that we previously thought were insolvable. We’re going to have new technologies. I think we’re going to have a broader view of the patient in their social context.

I think the real takeaway from that panel is a lot of optimism, actually, that there’s a group of people out there who are actually trying to solve the problems that patients have in 2017. The healthcare system of the future, 2025, 2030, whatever your future look is, is going to be that we are taking better care of our patients.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo